Monthly Archives: October 2010

Myriad Weighs In At The Federal Circuit

On October 22d, Myriad, represented by a Jones Day team, weighed in – literally – at the Federal Circuit with a 63 page brief supporting its appeal of Judge Sweet’s decision that claims directed to isolated DNA sequences are unpatentable … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , | Leave a comment

ACI 12th Advanced Forum on Biotech Patents

This well-known meeting/master patent drafting class will be held in Boston, MA from November 30 to December 2.  On December 1, Warren Woessner will be speaking on the topic, “Are Genes Patentable?  Examining the Potential Ramifications of Myriad and Developing Practical … Continue reading

Posted in Conferences and Classes | Tagged , , , , , | Leave a comment

US Patent Law – Discouraging an International Business Model?

In the recent decision of Solvay S.A. v. Honeywell International, Inc. (2009-1161, Fed. Cir. 2010), the Federal Circuit held that despite both being first to possess an invention in the U.S. and practicing reasonable diligence prior to filing, Honeywell did … Continue reading

Posted in Interferences | Tagged , , , , | Leave a comment

KSR Panel at AIPLA Annual Meeting

Thanks to all of you who attended (or tried to attend) the panel presentations on KSR Tuesday morning at the AIPLA Annual Meeting. We apologize, but were pleasantly surprised, that the room was too small to accommodate all who wished … Continue reading

Posted in Conferences and Classes, Obviousness | Tagged , , , | Leave a comment